Aqueous Extracts of Fructus Ligustri Lucidi Enhance the Sensitivity of Human Colorectal Carcinoma DLD-1 Cells to Doxorubicin-Induced Apoptosis via Tbx3 Suppression

Abstract

Chemoresistance has imposed a great challenge for cancer therapy. Fructus Ligustri Lucidi (FLL) is one of the commonest Chinese herbs that has been used for thousand years. This study shows that the aqueous extract of FLL (AFLL) enhanced the sensitivity of DLD-1 colon cancer cells to doxorubicin-induced apoptosis. Furthermore, Tbx3 expression was found to be suppressed by AFLL when the expression of tumor suppressor genes p14 and p53 were activated. Therefore, reduction of Tbx3 rescued the dysregulated P14^ARF-P53 signaling, which in turn contributed to the sensitivity of DLD-1 cells to doxorubicin-induced apoptosis. As a conclusion, the findings suggest that FLL has a potential of being an appealing agent for auxiliary chemotherapy in treatment of human colorectal carcinoma.

Keywords

sensitivity Fructus Ligustri Lucidi doxorubicin apoptosis

References

Benson AB Epidemiology, disease progression, and economic burden of colorectal cancer . J Manag Care Pharm. 2007;13: S5-S18.

Hawk ET , Levin B. Colorectal cancer prevention. J Clin Oncol. 2005;23:378-391.

Committee of National Pharmacopoeia. Pharmacopoeia of P. R. China. Beijing, China: Committee of National Pharmacopoeia; 2005:34.

Chen G. , Zhang LY , Wu XL , Ye JN Determination of mannitol and three sugars in Ligustrum lucidum Ait by capillary electrophoresis with electrochemical detection. Analytica . 2005;530:15-31.

Manu KA , Kuttan G. Ursolic acid induces apoptosis by activating p53 and caspase-3 gene expressions and suppressing NF-kappaB mediated activation of bcl-2 in B16F-10 melanoma cells. Int Immunopharmacol. 2008;8:974-981.

Yamai H. , Sawada N. , Yoshida T. , et al. Triterpenes augment the inhibitory effects of anticancer drugs on growth of human esophageal carcinoma cells in vitro and suppress experimental metastasis in vivo. Int J Cancer. 2009;125:952-960.

Bonaccorsi I. , Altieri F. , Sciamanna I. , et al. Endogenous reverse transcriptase as a mediator of ursolic acid’s anti-proliferative and differentiating effects in human cancer cell lines. Cancer Lett. 2008;263:130-139.

Li G. , Chan CY , Zhang JF , et al. the aqueous extract of Fructus Ligustri Lucidi regulates the differentiation of human mesenchymal stem cell. Int J Integr Biol. 2008;3:182-190.

Zhang Y. , Lai WP , Leung PC , Che CT , Wong MS Improvement of Ca balance by Fructus Ligustri Lucidi extract in aged female rats. Osteoporos Int. 2008;19:235-242.

10.

Carlson H. , Ota S. , Song Y. , et al. Tbx3 impinges on the P53 pathway to suppress apoptosis, facilitate cell transformation and block myogenic differentiation. Oncogene . 2002;21: 3827-3835.

11.

Jacobs JJ , Keblusek P. , Robanus-Maandag E. , et al. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19ARF) and is amplified in a subset of human breast cancers. Nat Genet. 2000;26:291-299.

12.

Temple HT Clinical evaluation and treatment of soft tissue tumors. Semin Musculoskelet Radiol. 1999;3:5-14.

13.

Lowe S. , Ruley H. , Jacks T. , Housman D. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 1993;74:957-967.

14.

Lowe S. , Bodis S. , McClatchey A. , et al. p53 status and the efficacy of cancer therapy in vivo. Science. 1994;266: 807-810.

15.

Blagosklonny M. , El- Deiry W. Acute overexpression of wt p53 facilitates anticancer drug-induced death of cancer and normal cells. Int J Cancer. 1998;75:933-940.

16.

Renard C. , Labalette C. , Armengol C. , et al. Tbx3 is a downstream target of the wnt-B catenin pathway and a critical mediator of B-catenin survival functions in liver cancer. Cancer Res. 2007;67:901-910.

17.

Bamshad M. , Lin RC , Law DJ , et al. Mutation in human TBX3 alter limb, apocrine and gential development in ulnar-mammary syndrome. Nat Genet. 1997 ; 16:311-315.

18.

Brummelkamp TR , Kortlever RM , Lingbeek M. , et al. TBX-3, the gene mutated in ulnar-mammary syndrome, is a negative regulator of p19ARF and inhibits senescence. J Biol Chem. 2002;277:6567-6572.

19.

Humbey O. , Pimkina J. , Zilfou JT , et al. The ARF tumor suppressor can promote the progression of some tumors. Cancer Res. 2008;68:9608-9613.

20.

Lingbeek ME , Jacobs JJ , van Lohuizen M. The T-box repressors TBX2 and TBX3 specifically regulate the tumor suppressor gene p14ARF via a variant T-site in the initiator . J Biol Chem. 2002;277:26120-26127.

21.

Yarosh W. , Barrientos T. , Esmailpour T. , et al. TBX3 is overexpressed in breast cancer and represses p14 ARF by interacting with histone deacetylases. Cancer Res. 2008; 68:693-699.